CT–MRI fusion improved contrast-free lung perfusion mapping for radiotherapy planning
Multimodal CT–MRI perfusion maps matched SPECT better than single-modality methods and reduced high-function lung dose in exploratory planning.
Multimodal CT–MRI perfusion maps matched SPECT better than single-modality methods and reduced high-function lung dose in exploratory planning.
AI-assisted planning cut average planning time from about two hours to 30 minutes, but three of 12 plans required manual hotspot correction.
A phantom-derived model predicted SCART central target radius with R² values of 0.991–0.999, but clinical validation remains absent.
ECHO generated consistent lung IMRT and VMAT plans while reducing active planner time by approximately 90 minutes per case.
Automatically predicted coronary habitats captured most arteries and enabled substantial dose reductions in three retrospectively replanned thoracic cases.
Robust photon planning usually improved uncertainty-resistant target coverage, but modelling, evaluation, and reporting varied substantially across the literature.
Low-cost diagnostic and treatment phantoms improved students’ self-reported understanding of radiation medicine, although formal learning outcomes were not assessed.
A model trained at one centre closely predicted doses in 560 head and neck plans from six external institutions.
A single knowledge-based model generated comparable ocular plans for 25 Gy once, 42 Gy in three fractions and 50 Gy in five.
Upright carbon ion treatment plans achieved target coverage, organ sparing and simulated robustness comparable with conventional supine plans.
The framework linked complete planning and delivery data for 13,871 plans with 99.76% success across two clinics.
Surface-contacted 3D boluses generally narrowed lateral penumbra and reduced surrounding dose versus a nozzle-mounted range shifter in proton PBS.
MIM-based skeletal muscle index measurement matched ImageJ while reducing processing time from 10 to 3.5 minutes.
RapidPlan reduced several organ-at-risk dose metrics while maintaining comparable target coverage in head and neck and brain radiotherapy planning.
Four epidermolysis bullosa patients tolerated radiotherapy without greater-than-expected cutaneous toxicity, despite maximum skin dose up to 50.4 Gy.